Abstract
Background and aimsLEVO is a novel inodilator developed to treat heart failure. Biotransformation of LEVO in the intestinal tract gives rise to intermediate metabolites with prolonged beneficial haemodynamic effects. There...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have